¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activity coefficient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mental activity
    Á¤½ÅȰµ¿
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • partial agonistic activity
    ºÎºÐÀÛ¿ëÁ¦È°¼º
  • specific activity
    1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sexual activity
    ¼ºÈ°µ¿
  • apparent diffusion coefficient
    °Ñº¸±âÈ®»ê°è¼ö
  • attenuation coefficient
    °¨¼è°è¼ö
  • affinity coefficient
    ģȭ°è¼ö
  • absorption coefficient
    Èí¼ö°è¼ö
  • binomial coefficient
    ÀÌÇ×°è¼ö
  • biological coefficient
    »ý¹°ÇÐÀû°è¼ö
  • blood gas solubility coefficient
    Ç÷¾×°¡½º¿ëÇØ°è¼ö
  • coefficient
    °è¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molar activity
    ¸ôȰ¼º
  • partial agonistic activity
    ºÎºÐÈ¿´ÉȰ¼º
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • reflex gamma activity
    ¹Ý»ç°¨¸¶È°µ¿
  • sexual activity
    ¼ºÈ°µ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • time-activity curve
    ½Ã°£¹æ»ç´É°î¼±
  • professional activity study
    Àü¹®°¡È°µ¿¿¬±¸
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sperm activity grade test
    Á¤Àڿµî±Þ°Ë»ç
  • absorption coefficient
    Èí¼ö°è¼ö
  • affinity coefficient
    ģȭ°è¼ö
  • apparent diffusion coefficient
    °Ñº¸±âÈ®»ê°è¼ö
  • attenuation coefficient
    °¨¼è°è¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
  • activity therapy
    Ȱµ¿¿ä¹ý(¡­èþÛö).
  • activity therapy
    Ȱµ¿ ¿ä¹ý
  • activity, antibacterial
    Ç×±ÕÀÛ¿ë
  • amylase activity
    ¾Æ¹Ð¶óÁ¦-Ȱ¼ºµµ
  • antibacterial activity
    Ç×±ÕÀÛ¿ë(ù÷жíÂéÄ), Ç×±ÕȰ¼º(ù÷жüÀàõ).
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzyme activity
    È¿¼ÒȰ¼º
  • enzyme activity
    È¿¼ÒȰ¼ºµµ
  • epidemiologic activity
    ¿ªÇÐÀû Ȱµ¿(ËçÌ°Ëø Ì·ËÄ).
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
  • insulin like activity =ILa
    Àν¶¸°¾çȰ¼º(ÀÛ¿ë).
  • insulin-like activity substance
    Àν¶¸°¾çȰ¼º¹°Áú.
  • intrinsic activity
    ¾à¸®³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic activity
    ³»È°¼º(Ò®üÀàõ).[¾à¸®]³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic sympathomimetic activity
    ³»Àμº ±³°¨½Å°æÀ¯»çÀÛ¿ë.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
  • vibrational optical activity
    Áøµ¿ ±¤ÇРȰ¼º(òÉÔÑÎÃùÊ üÀàõ)
  • absorption coefficient
    Èí¼ö°è¼ö (ýåâ¥Íªâ¦)
  • adsorption coefficient
    ÈíÂø°è¼ö(ýåó·Ìõâ¦)
  • allosteric coefficient
    ¾Ë·Î½ºÅ׸® °è¼ö(Ìõâ¦)
  • Bohr coefficient
    º¸¾î °è¼ö(Ìõâ¦)
  • Bunsen absorption coefficient
    ºÐÁ¨ Èí¼ö°è¼ö(ýåâ¥Ìõâ¦)
  • Bunsen solubility coefficient
    ºÐÁ¨ ¿ëÇØµµ°è¼ö(éÁú°ÓøÌõâ¦)
  • coefficient
    °è¼ö(Ìõâ¦)
  • coefficient of coincidence
    µ¿½Ã°è¼ö(ÔÒãÁÌõâ¦)
  • coefficient of correlation
    »ó°ü°è¼ö(ßÓμÌõâ¦)
  • coefficient of variation
    ºÐ»ê°è¼ö(ÝÂߤÌõâ¦)
  • coefficient of viscosity
    Á¡µµ°è¼ö(ïÄÓøÌõâ¦)
  • conversion coefficient
    Àüȯ°è¼ö(ï®üµÌõâ¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
EGRAC erythrocyte glutathione reductase activity coefficient
CIA chemiluminescent immunoassay; chymotrypsin inhibitor activity; colony-inhibiting activity; congenita...
ECA electrical control activity; electrocardioanalyzer; endothelial cytotoxic activity; enterobacterial ...
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
COV Coefficient of variation
CV coefficient variation
% CV coefficient of variance
CC Correlation coefficient
Ds diffusion coefficient
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intraclass correlation coefficient
    °Ë»çÀÚ°£ ½Å·Úµµ¿¡ ´ëÇÑ µî±Þ ³» »ó°ü °è¼ö
  • isotonic coefficient
    µîÀå¼ö
  • linear coefficient of expansion
    ¼± ÆØÃ¢ °è¼ö
    °íüÀÇ ¿­ ÆØÃ¢¿¡ µû¸¥ ±æÀÌÀÇ º¯È­ ºñÀ². 0 ¡É¿¡¼­ ±æÀÌ lÀÎ ¹°Ã¼°¡ ¿Âµµ º¯È­ d¿¡ ´ëÇØ dl¸¸Å­ ¿­ ÆØÃ¢ÇÒ ¶§,
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • mass absorption coefficient
    Áú·® Èí¼ö °è¼ö
  • molecular extinction coefficient
    ºÐÀÚ ¼Ò¸ê °è¼ö
  • osmotic coefficient
    »ïÅõ °è¼ö
  • oxygen coefficient
    »ê¼Ò °è¼ö
  • partition coefficient
    ºÐ¹è °è¼ö
  • penetration coefficient
    ħÅõ °è¼ö
  • pseudodiffusion coefficient
    À§È®»ê °è¼ö
  • reflectance coefficient
    ¹Ý»ç °è¼ö
  • uniformity coefficient
    µî°è¼ö
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
    1. Ȱ¼ºÈ­µÈ »óÅÂ. ¾î¶² È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ´É·Â. ¾î¶² ÀÛ¿ë ¶Ç´Â ±â´ÉÀÇ ¿¬Àå. 2. ºñÀÌ»óÀûÀÎ ¿ë¾×¿¡¼­ È¿°úÀûÀÎ ³óµµ¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Â ¿­¿ªÇÐÀûÀÎ ¾ç. ¸¸¾à ³óµµ°¡ Ȱµ¿µµ·Î ´ëü µÈ´Ù¸é ÆòÇü»ó¼ö¿¡ °üÇÑ ¹æÁ¤½Ä, ÀüÀ§, »ïÅõ¾Ð, ²ú´Â Á¡ ¿À¸§, ¾î´Â Á¡ ³»¸², Èֹ߼º ¿ëÁúÀÇ Áõ±â¾ÐÀº Èñ¼® ¿ë¾×¿¡¼­ ¸ðµç ³óµµ¿¡ ´ëÇØ °íÁ¤µÈ Á¤È®ÇÑ ¹æÁ¤½ÄÀÇ ±Ù»ç °ªÀ¸·Î ¹Ù²î¾î Áø´Ù. Ȱµ¿µµ´Â ºñÀÌ»óÀûÀÎ °ÍÀ¸·ÎºÎÅÍ ÃøÁ¤µÈ ºÎÇǰ¡ ¾ø´Â ¼ýÀÚ, Ȱµ¿°è¼ö¿Í »ý»ê¹°ÀÇ ³óµµ¿Í °°´Ù.
  • activity index
    Ȱµ¿ Áö¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
drug activity A measure of the physiological response a drug produces. A less active drug produces less response (and visa versa).
(12 Dec 1998)
insulin-like activity A measure of substances, usually in plasma, that exert biologic effects similar to those of insulin in various bioassays; sometimes used as a measure of plasma insulin concentrations; always gives higher values than immunochemical techniques for the measurement of insulin.
(05 Mar 2000)
intrinsic sympathomimetic activity The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system.
(05 Mar 2000)
optical activity The ability of a material to rotate the plane of polarized light.
(09 Oct 1997)
triggered activity One or a series of spontaneously generated heart beats originating from an action potential that produces an after-depolarisation which reaches activation threshold.
(05 Mar 2000)
unit of thyrotrophic activity The activity of an amount of an extract of the anterior lobe of the hypophysis which, given daily for 5 days, will cause the thyroid of a guinea pig (weighing 200 g) to reach a weight of 600 mg.
(05 Mar 2000)
zone of polarizing activity <cell biology> The small group of mesenchyme cells in avian limb buds that is located at the posterior margin of the developing bud and that produces a substance, possibly retinoic acid, that provides positional information to the developing limb bud.
(18 Nov 1997)
absorption coefficient <physics> Measures the degree of wave absorption defined as the fraction of wave energy lost as the wave travels a unit distance.
See: absorption.
(15 Jan 1998)
attenuation coefficient 1. <radiobiology> Compton: The fractional number of photons removed from a beam of radiation per unit thickness of material through which it is passing as a result of Compton effect interactions.
2. Linear: The fractional number of photons removed from a beam of radiation per unit thickness of material through which it is passing due to all absorption and scattering processes.
3. Pair Production: That fractional decrease in the intensity of a beam of ionising radiation due to pair production in a medium through which it passes.
4. Photoelectric Effect: That fractional decrease in the intensity of a beam of ionising radiation due to photoelectric effect in a medium through which it passes.
(16 Dec 1997)
biological coefficient Rarely used term denoting the energy expended by the body at rest.
(05 Mar 2000)
Bunsen's solubility coefficient The milliliters of gas STPD dissolved per milliliter of liquid and per atmosphere (760 mm Hg) partial pressure of the gas at any given temperature.
(05 Mar 2000)
velocity coefficient The rate of transformation of a unit mass of substance in a chemical reaction.
(05 Mar 2000)
recombination coefficient <radiobiology> The rate of recombination of positive ions with electrons (or negative ions) in a gas, per unit volume, divided by the product of the particle densities of the two species (positive ions and electrons/negative ions) involved.
(09 Oct 1997)
mass attenuation coefficient <physics> The mass attenuation coefficient, u/p, of a material for uncharged ionising particles is the quotient of DN/N by pdl, where DN/N is the fraction of particles that experience interactions in traversing a distance dl in a material of density p.
(16 Dec 1997)
mass energy absorption coefficient <physics> The mass energy absorption coefficient, uen/p of a material for uncharged ionising particles is the product of the mass energy transfer coefficient, utr/p and (1 - g) where g is the fraction of the energy of secondary charged particles that is lost to bremsstrahlung in the material.
(16 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á